JPWO2022099003A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022099003A5 JPWO2022099003A5 JP2023526888A JP2023526888A JPWO2022099003A5 JP WO2022099003 A5 JPWO2022099003 A5 JP WO2022099003A5 JP 2023526888 A JP2023526888 A JP 2023526888A JP 2023526888 A JP2023526888 A JP 2023526888A JP WO2022099003 A5 JPWO2022099003 A5 JP WO2022099003A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- antigen
- influenza
- mrna
- mrna molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063110965P | 2020-11-06 | 2020-11-06 | |
| US63/110,965 | 2020-11-06 | ||
| US202163212523P | 2021-06-18 | 2021-06-18 | |
| US63/212,523 | 2021-06-18 | ||
| EP21315198 | 2021-10-13 | ||
| EP21315198.8 | 2021-10-13 | ||
| PCT/US2021/058250 WO2022099003A1 (en) | 2020-11-06 | 2021-11-05 | Lipid nanoparticles for delivering mrna vaccines |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023550600A JP2023550600A (ja) | 2023-12-04 |
| JPWO2022099003A5 true JPWO2022099003A5 (https=) | 2025-06-17 |
| JP2023550600A5 JP2023550600A5 (https=) | 2025-06-17 |
| JP7817257B2 JP7817257B2 (ja) | 2026-02-18 |
Family
ID=86184333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023526888A Active JP7817257B2 (ja) | 2020-11-06 | 2021-11-05 | ｍＲＮＡワクチンを送達するための脂質ナノ粒子 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4240335A1 (https=) |
| JP (1) | JP7817257B2 (https=) |
| KR (1) | KR20230104223A (https=) |
| CN (1) | CN116406299A (https=) |
| AU (1) | AU2021374976A1 (https=) |
| CA (1) | CA3194325A1 (https=) |
| CO (1) | CO2023005218A2 (https=) |
| IL (1) | IL302631A (https=) |
| MX (1) | MX2023005203A (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017020026A1 (en) | 2015-07-30 | 2017-02-02 | Modernatx, Inc. | Concatemeric peptide epitopes rnas |
| TW201729835A (zh) | 2015-10-22 | 2017-09-01 | 現代公司 | 呼吸道病毒疫苗 |
| WO2019148101A1 (en) | 2018-01-29 | 2019-08-01 | Modernatx, Inc. | Rsv rna vaccines |
| EP4612301A1 (en) * | 2022-11-03 | 2025-09-10 | ModernaTX, Inc. | Chemical stability of mrna |
| CN118021957A (zh) * | 2022-11-11 | 2024-05-14 | 深圳先进技术研究院 | 一种编码抗禽流感H7N9病毒抗体的mRNA及其制法和应用 |
| CN118021956A (zh) * | 2022-11-11 | 2024-05-14 | 深圳先进技术研究院 | 一种编码抗禽流感H7N9病毒抗体的mRNA及其制法和应用 |
| WO2025054383A1 (en) * | 2023-09-06 | 2025-03-13 | Modernatx, Inc. | Chemical stability of mrna |
| WO2025092866A1 (zh) * | 2023-10-31 | 2025-05-08 | 仁景(苏州)生物科技有限公司 | 一种多价流感mRNA疫苗 |
| CN120053395A (zh) * | 2023-11-30 | 2025-05-30 | 苏州维益生物科技有限公司 | 含二硫键的核酸-脂质颗粒、药物、用途、及制备方法 |
| CN118725043B (zh) * | 2024-06-27 | 2025-12-05 | 中国人民解放军陆军军医大学 | 用于递送核酸的多肽-脂质组合物及其应用和mRNA疫苗 |
| CN119746089B (zh) * | 2025-03-07 | 2025-06-13 | 细胞生态海河实验室 | 脂质纳米颗粒冷冻保护剂 |
| CN121466311A (zh) * | 2026-01-09 | 2026-02-06 | 羿美诚健(上海)生物医药有限公司 | 一种脂质组合物及其在核酸递送中的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170143848A1 (en) * | 2014-03-24 | 2017-05-25 | Shire Human Genetic Therapies, Inc. | Mrna therapy for the treatment of ocular diseases |
| ES2949540T3 (es) * | 2015-06-19 | 2023-09-29 | Massachusetts Inst Technology | 2,5-piperazinadionas sustituidas con alquenilo y su uso en composiciones para suministrar un agente a un sujeto o una célula |
| TW202309002A (zh) * | 2021-04-15 | 2023-03-01 | 美商轉譯生技公司 | 基於「古德」緩衝液的陽離子脂質 |
-
2021
- 2021-11-05 CA CA3194325A patent/CA3194325A1/en active Pending
- 2021-11-05 EP EP21815832.7A patent/EP4240335A1/en active Pending
- 2021-11-05 CN CN202180073816.5A patent/CN116406299A/zh active Pending
- 2021-11-05 IL IL302631A patent/IL302631A/en unknown
- 2021-11-05 KR KR1020237018750A patent/KR20230104223A/ko active Pending
- 2021-11-05 MX MX2023005203A patent/MX2023005203A/es unknown
- 2021-11-05 JP JP2023526888A patent/JP7817257B2/ja active Active
- 2021-11-05 AU AU2021374976A patent/AU2021374976A1/en active Pending
-
2023
- 2023-04-25 CO CONC2023/0005218A patent/CO2023005218A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12239735B2 (en) | Lipid nanoparticles for delivering mRNA vaccines | |
| JP7817257B2 (ja) | ｍＲＮＡワクチンを送達するための脂質ナノ粒子 | |
| JPWO2022099003A5 (https=) | ||
| US20230043128A1 (en) | Multivalent influenza vaccines | |
| ES2377884T3 (es) | Vacunas contra la gripe que incluyen combinaciones de adyuvantes particulados e inmunopotenciadores | |
| CN102781469B (zh) | 用于生产流感疫苗的方法 | |
| Levina et al. | Nanoparticle-mediated nonviral DNA delivery for effective inhibition of influenza A viruses in cells | |
| IL321503A (en) | Recombinant virus, composition comprising the same, and uses thereof | |
| US20190314486A1 (en) | Influenza hemagglutinin protein vaccines | |
| JPWO2022264109A5 (https=) | ||
| KR20240002207A (ko) | 코로나바이러스 백신 | |
| CN121419787A (zh) | 多价流感mRNA疫苗 | |
| US20240156966A1 (en) | A sirna drug, a pharmaceutical composition, a sirna-small molecule drug conjugate, and the application thereof | |
| US20250269035A1 (en) | Inhalable lipid nanoparticle, lipid-charged molecule conjugate, and lipid-zwitterionic molecule conjugate | |
| JPWO2021202734A5 (https=) | ||
| RU2023114690A (ru) | ЛИПИДНЫЕ НАНОЧАСТИЦЫ ДЛЯ ДОСТАВКИ mRNA-ВАКЦИНA | |
| RU2024101100A (ru) | Поливалентные вакцины против гриппа | |
| CN117580568A (zh) | 多价流感疫苗 | |
| CN101420948A (zh) | 静脉内抗病毒治疗 | |
| JPWO2022244825A5 (https=) | ||
| RU2860421C2 (ru) | ЛИПИДНЫЕ НАНОЧАСТИЦЫ ДЛЯ ДОСТАВКИ mRNA-ВАКЦИНЫ | |
| HK40096671A (zh) | 用於递送mrna疫苗的脂质纳米颗粒 | |
| JP2025536956A (ja) | 目的遺伝子ｒｎａ製剤 | |
| JPWO2023079113A5 (https=) |